This work was funded by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, RS-2025-02218354, Sun-Ki Kim, Korea Evaluation Institute of Industrial Technology, RS-2025-02307907, Sun-Ki Kim, Chung-Ang University, Graduate Research Scholarship (Academic Scholarship for the College of Biotechnology, Sang-Hun Do, Natural Resources) in 2024, Sang-Hun Do
Taken together these suggest that although GLP1R agonists may increase the risk of pancreatitis and thyroid cancer in rodents, that it has yet to be confirmed in humans
However, the right dosage is key to balancing effectiveness and minimizing side effects
Participants lost nearly 5% of body weight in four weeks
The science has not